Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Ying Jen

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Haematologica|May 14, 2026
Outcomes of patients diagnosed with myelodysplastic syndrome or acute myeloid leukemia following solid organ transplantationCharan Thej Reddy Vegivinti, Guillermo Montalban-Bravo, Kelly Chien, et al.
American Journal of Hematology|August 28, 2024
A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemiaWei-Ying Jen, Elias Jabbour, Nicholas J Short, et al.
JCO Oncology Practice|October 16, 2023
Factors Affecting Patient and Caregiver Preferences for Treatment of Myeloma and Indolent LymphomaChia Jie Tan, Melinda Si Yun Tan, Chandramouli Nagarajan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 30, 2018
A New Model for Risk Stratification of Patients With Acute Pulmonary EmbolismWei-Ying Jen, Young Seok Jeon, Pipin Kojodjojo, et al.
Cancers|July 27, 2022
Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and AzacitidineShin Yeu Ong, Melinda Tan Si Yun, Nurul Aidah Abdul Halim, et al.
British Journal of Haematology|April 11, 2024
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expressionWei-Ying Jen, Koji Sasaki, Sanam Loghavi, et al.
Leukemia & Lymphoma|May 15, 2024
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemiaJennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, et al.
Cancer Medicine|November 19, 2024
A Combinatorial Functional Precision Medicine Platform for Rapid Therapeutic Response Prediction in AMLNoor Rashidha Binte Meera Sahib, Jameelah Sheik Mohamed, Masturah Bte Mohd Abdul Rashid, et al.
Blood Cancer Journal|November 25, 2025
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guideWei-Ying Jen, Curtis A Lachowiez, Jennifer Marvin-Peek, et al.
Leukemia|January 8, 2025
EZH2 modulates mRNA splicing and exerts part of its oncogenic function through repression of splicing factors in CMLReinhard Brunmeir, Li Ying, Junli Yan, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Haematologica|May 14, 2026
Outcomes of patients diagnosed with myelodysplastic syndrome or acute myeloid leukemia following solid organ transplantationCharan Thej Reddy Vegivinti, Guillermo Montalban-Bravo, Kelly Chien, et al.
American Journal of Hematology|August 28, 2024
A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemiaWei-Ying Jen, Elias Jabbour, Nicholas J Short, et al.
JCO Oncology Practice|October 16, 2023
Factors Affecting Patient and Caregiver Preferences for Treatment of Myeloma and Indolent LymphomaChia Jie Tan, Melinda Si Yun Tan, Chandramouli Nagarajan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 30, 2018
A New Model for Risk Stratification of Patients With Acute Pulmonary EmbolismWei-Ying Jen, Young Seok Jeon, Pipin Kojodjojo, et al.
Cancers|July 27, 2022
Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and AzacitidineShin Yeu Ong, Melinda Tan Si Yun, Nurul Aidah Abdul Halim, et al.
British Journal of Haematology|April 11, 2024
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expressionWei-Ying Jen, Koji Sasaki, Sanam Loghavi, et al.
Leukemia & Lymphoma|May 15, 2024
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemiaJennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, et al.
Cancer Medicine|November 19, 2024
A Combinatorial Functional Precision Medicine Platform for Rapid Therapeutic Response Prediction in AMLNoor Rashidha Binte Meera Sahib, Jameelah Sheik Mohamed, Masturah Bte Mohd Abdul Rashid, et al.
Blood Cancer Journal|November 25, 2025
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guideWei-Ying Jen, Curtis A Lachowiez, Jennifer Marvin-Peek, et al.
Leukemia|January 8, 2025
EZH2 modulates mRNA splicing and exerts part of its oncogenic function through repression of splicing factors in CMLReinhard Brunmeir, Li Ying, Junli Yan, et al.
Pageof 5